10-K/A: NRC Health Files 10-K/A for 2025 Governance Disclosures

NRC Health filed an amendment to its 2025 Annual Report to provide required director and executive compensation disclosures.

Summary

• This filing is an amendment (Form 10-K/A) to the 2025 Annual Report originally filed on March 5, 2026.
• The primary purpose is to include Part III information (Directors, Executive Officers, and Corporate Governance) that was omitted from the original filing.
• The company confirms that a definitive proxy statement containing this information will not be filed within the 120-day window following the fiscal year-end.
• The amendment includes updated certifications from the CEO and CFO pursuant to the Sarbanes-Oxley Act.
• No new financial statements are included in this amendment.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing; while it corrects a disclosure delay, it also highlights internal administrative lapses and the need for retroactive compensation adjustments.

Positives

• Strong shareholder support for executive compensation, with approximately 99% of votes cast in favor during the May 2025 annual meeting.
• Successful transition of leadership with the appointment of Trent Green as CEO and Shane Harrison as CFO in 2025.
• Implementation of a clawback policy covering current and former officers subject to Section 16 of the Exchange Act.

Negatives

• Failure to file a definitive proxy statement within 120 days of the fiscal year-end, necessitating this 10-K/A filing.
• Several late Section 16(a) filings reported for directors and executive officers during 2025.
• Uncertainty regarding the tax treatment of 2025 equity awards led to the need for amendments and additional cash bonuses to cover tax obligations.

Risks

• Reliance on a small number of key personnel and the recent significant turnover in the executive leadership team.
• Potential for future restatements of financial results triggering the company's clawback policy.
• Market volatility affecting the value of equity-based compensation and the retention of key executives.

Future Outlook

The company is focused on executing its strategic plan under new leadership, with an emphasis on aligning executive incentives with long-term stockholder value through equity ownership.

Management Comments

• The Compensation Committee believes the total compensation paid to Named Executive Officers in 2025 was consistent with financial performance and individual contributions.
• The company aims to align the compensation structure of the executive team to deliver on the strategic plan.

Industry Context

StockSavvy.ai notes that NRC Health is navigating a significant leadership transition while addressing administrative compliance gaps common in mid-cap healthcare technology firms.

Comparison to Industry Standards

• The company does not use a specific peer group for compensation benchmarking due to the lack of direct publicly traded peers.
• The company utilizes the Russell 2000 Index for stock performance comparisons as permitted by SEC regulations.

Management Changes

Corporate Governance

Legal Proceedings

• None disclosed.

Related Party Transactions

• None disclosed for 2025.

Stakeholder Impact

• Shareholders are provided with the required governance and compensation disclosures previously omitted.
• Executive officers are subject to new clawback provisions and revised equity award terms.

Next Steps

• Continued execution of the 2025 strategic plan.
• Ongoing monitoring of executive compensation and equity vesting schedules.

Key Dates

Keywords

NRC Health, 10-K/A, Executive Compensation, Corporate Governance, SEC Filing, Healthcare Technology